Study Overview
Sex: Male
Age: 18 Years to 65 Years (Adult, Older Adult)
No Study Documents
Study Overview
Sex: Male
Age: 18 Years to 65 Years (Adult, Older Adult)
No Study Documents
BGB-3111-112
Completed
The Effect of Moderate CYP3A Inducer Rifabutin on the Pharmacokinetics of Zanubrutinib in Healthy Males
Beigene Study ID
BGB-3111-112
ClinicalTrials.gov ID
Sex: Male
Age: 18 Years to 65 Years (Adult, Older Adult)
No Study Documents
Sex: Male
Age: 18 Years to 65 Years (Adult, Older Adult)
No Study Documents